BRCA2 and neoplasm: Of the 40 cases with WGS and derived mutational signatures, the 3 cases with the highest levels of signature 3 (accounting for 33.8%–38.8% of the tumor’s somatic variants) included the 2 cases with a pathogenic germline BRCA2 variant (Supplementary Figure 4).